Personalized interventions for older adults with mild behavioral impairment

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on older adults diagnosed with mild behavioral impairment (MBI) to explore personalized interventions aimed at improving neuropsychiatric symptoms and delaying the progression to dementia. Utilizing the Landmark model, the research will assess various influencing factors on MBI and dementia progression through dynamic risk prediction. The goal is to develop tailored non-drug interventions that address the unique needs of each patient, thereby enhancing their quality of life and promoting healthy aging.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Meet the ISTAART diagnostic criteria for MBI;
* Age ≥60 years old;
* No obvious visual or hearing impairment;
* Have the ability of language communication, can complete the scale assessment.

Exclusion Criteria:

* Patients with severe physical diseases and unable to complete cognitive function screening;
* Patients with other neurological diseases and serious medical diseases that can cause brain dysfunction.

Where it's running

• Fujian Provincial Hospital
  Fuzhou, Fujian, China Recruiting

Study contacts

• Study coordinator: Shi Yanhong
• Email: Cordelia88@163.com
• Phone: 89-15150947040

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Non-invasive brain stimulation plus computer-based memory training for mild cognitive impairment

  This trial will test whether a short course of non-invasive brain stimulation combined with one of two computer-based brain-training programs helps people aged 60–85 with mild cognitive impairment improve memory, thinking, mood, and daily function.

  Recruiting Medical University of South Carolina · Charleston, South Carolina · NCT07526740

• Developing and testing the Liver Cirrhosis Cognitive Decline Scale (LiCCoS)

  This project will test a short questionnaire called LiCCoS to see if it can spot thinking and everyday mental problems in adults with liver cirrhosis.

  Recruiting University of Malaya · Ambāla, Haryana · NCT07418008

• Carotid artery wall viscosity and memory problems in older adults

  This project will test whether the viscous behavior of the carotid artery wall is linked to memory problems in people over 70 with memory complaints, Alzheimer's disease, or vascular dementia.

  Recruiting University Hospital, Rouen · Rouen · NCT07205003

• NeuroFirst brain protection for adults having heart bypass surgery

  This trial tests whether a bundled anesthesia approach called NeuroFirst can help people aged 60 and older having planned heart surgery with cardiopulmonary bypass avoid silent brain infarcts and thinking or memory problems after surgery.

  Recruiting at 5 sites Chinese Academy of Medical Sciences, Fuwai Hospital · Beijing, Beijing Municipality and 4 other locations · NCT07048002

• Nutrition-based interventions to prevent cognitive decline

  This study is testing if a 6-month nutrition program can help adults at higher risk for dementia keep their thinking skills sharp.

  Recruiting at 2 sites Instituto de Saude Publica da Universidade do Porto · Porto, Portugal and 1 other locations · NCT06853405

• Oral midazolam to help deliver care for older adults with neurocognitive disorders who refuse care

  This study will try a short-acting oral midazolam to help nurses and caregivers give essential care to older adults with moderate to severe neurocognitive disorders who resist or refuse care.

  Recruiting Phase 2 University Hospital, Grenoble · Grenoble, Isere · NCT06638710

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.